Organon & Co | OGN - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Celltrion KRW 11.84B 1.34B 2026-03
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 11.8B 2.17B 2026-06
Gilead Sciences USD -7.53B 10.11B 2026-06
Glaxosmithkline GBP 2.14B 312M 2026-03
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Medical Developments International AUD -149K 466K 2025-06
Merck USD -3.53B 6.95B 2026-03
Neuren Pharmaceuticals AUD 19.21M 9.35M 2025-12
Novartis USD 3.84B 1.33B 2026-03
Organigram Holdings CAD -921K 40.8M 2026-03
Organon & Co USD 183M 30M 2026-06
Pharma Mar EUR -993K 2.59M 2026-06
Qiagen NV USD 157.9M 72.08M 2026-06
Sartorius EUR 127M 30.8M 2026-06
Tilray USD -39.96M 39.19M 2025-09
Zealand Pharma A/S -394M 12.5M 2026-03